⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cystamine SCHEMBL9559242 | 1.00 | TSHR (0.67) | — | |
| Cystamine SCHEMBL11040994 | 0.82 | — | — | |
| Cystamine SCHEMBL3648870 | 0.82 | TSHR (1.00) | — | |
| Cystamine SCHEMBL43866 | 0.82 | — | — | |
| SCHEMBL94190 | 0.82 | — | — | |
| Cystamine SCHEMBL9242006 | 0.81 | TSHR (0.59) | — | |
| Cystamine SCHEMBL9193499 | 0.78 | — | — | |
| Cystamine SCHEMBL196510 | 0.78 | — | — | |
| Cystamine SCHEMBL320311 | 0.78 | MAPT (1.00) | — | |
| Cystamine SCHEMBL1526281 | 0.78 | TSHR (0.91) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1789091-B1 | PRODRUGS CONTAINING NOVEL BIO-CLEAVABLE LINKERS | PIRAMAL LIFE SCIENCES LTD (IN) | 2010-08-25 | — | — | EP | claimed |
| EP-2075011-A2 | Prodrugs Containing Bio-Cleavable Linkers | Piramal Life Sciences Limited (IN) | 2009-07-01 | — | — | EP | claimed |
| US-20260035369-A1 | VINCAMINE DERIVATIVES, PREPARATION METHOD THEREFOR, AND USE THEREOF | UNIV SOUTHWEST (CN) | 2026-02-05 | — | — | US | disclosed |
| WO-2024250427-A1 | VINCAMINE DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF | 西南大学 | 2024-12-12 | — | — | WO | disclosed |
| WO-2022130046-A1 | N-1 BRANCHED IMIDAZOQUINOLINES, CONJUGATES THEREOF, AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-06-23 | — | — | WO | disclosed |
| CN-114341141-A | Camptothecin derivatives having a disulfide moiety and a piperazine moiety | 太阳医药高级研究有限公司 | 2022-04-12 | — | — | CN | disclosed |
| WO-2021005583-A1 | CAMPTOTHECIN DERIVATIVES WITH A DISULFIDE MOIETY AND A PIPERAZINE MOIETY | SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) | 2021-01-14 | — | — | WO | disclosed |
| US-10251845-B2 | Fatty acid cysteamine conjugates and their use as activators of autophagy | CATABASIS PHARMACEUTICALS, INC. (US) | 2019-04-09 | — | — | US | disclosed |
| US-20170258741-A1 | FATTY ACID CYSTEAMINE CONJUGATES AND THEIR USE AS ACTIVATORS OF AUTOPHAGY | CATABASIS PHARMACEUTICALS, INC. (US) | 2017-09-14 | — | — | US | disclosed |
| US-20170258741-A1 | FATTY ACID CYSTEAMINE CONJUGATES AND THEIR USE AS ACTIVATORS OF AUTOPHAGY | CATABASIS PHARMACEUTICALS, INC. (US) | 2017-09-14 | — | — | US | disclosed |
| WO-2016086136-A1 | FATTY ACID CYSTEAMINE CONJUGATES OF CFTR MODULATORS AND THEIR USE IN TREATING MEDICAL DISORDERS | CATABASIS PHARMACEUTICALS, INC. (US) | 2016-06-02 | — | — | WO | disclosed |
| EP-2266623-A2 | Prodrugs containing novel bio-cleavable linkers | Piramal Life Sciences Limited (IN) | 2010-12-29 | — | — | EP | disclosed |
| EP-2266625-A2 | Prodrugs Containing Novel Bio-Cleavable Linkers | Piramal Life Sciences Limited (IN) | 2010-12-29 | — | — | EP | disclosed |
| EP-2266622-A2 | Prodrugs containing novel bio-cleavable linkers | Piramal Life Sciences Limited (IN) | 2010-12-29 | — | — | EP | disclosed |
| EP-1789091-B1 | PRODRUGS CONTAINING NOVEL BIO-CLEAVABLE LINKERS | PIRAMAL LIFE SCIENCES LTD (IN) | 2010-08-25 | — | — | EP | disclosed |
| US-20090258416-A1 | POLYMER MICELLE COMPLEX INCLUDING NUCLEIC ACID | THE UNIVERSITY OF TOKYO (JP) | 2009-10-15 | — | — | US | disclosed |
| EP-2075011-A2 | Prodrugs Containing Bio-Cleavable Linkers | Piramal Life Sciences Limited (IN) | 2009-07-01 | — | — | EP | disclosed |
| EP-2075011-A2 | Prodrugs Containing Bio-Cleavable Linkers | Piramal Life Sciences Limited (IN) | 2009-07-01 | — | — | EP | disclosed |
| WO-2009037473-A2 | NUCLEOBASE CHARACTERISATION | UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2009-03-26 | — | — | WO | disclosed |
| US-6607653-B1 | Tin-copper alloy plating bath, tin-copper-bismuth alloy plating bath or tin-copper-silver alloy plating bath containing a soluble metal compound and a specific sulfur-containing compound. The plating bath of the alloy with | DAIWA FINE CHEMICALS CO., LTD. (JP) | 2003-08-19 | — | — | US | disclosed |